Study for Treatment of Chronic Diabetic Foot Ulcers With the Investigational Allogeneic Cell Therapy Product, hOMSC200
Conditions: Diabetic Foot; Diabetic Foot Ulcer; Diabetic Foot Ulcer Neuropathic Interventions: Biological: hOMSC200; Other: Placebo Sponsor: Cytora Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials